Helius Medical Further Expands Stroke Clinical Program With The Addition Of Brooks Rehabilitation Hospital; Starting In January 2024, Enrolment Of ~40 Participants Is Expected While Full Enrolment By The End Of 2024
Portfolio Pulse from Benzinga Newsdesk
Helius Medical is expanding its stroke clinical program by adding Brooks Rehabilitation Hospital as a second site. The program, starting in January 2024, aims to enroll approximately 40 participants, with full enrollment expected by the end of 2024. The study will use the Portable Neuromodulation Stimulator (PoNS) to assess its effectiveness in treating gait and balance deficits in stroke patients. The results will contribute to the efforts of obtaining U.S. authorization for PoNS under its breakthrough designation for stroke treatment.
January 11, 2024 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Helius Medical's partnership with Brooks Rehabilitation Hospital to expand its stroke clinical program could positively impact the company's efforts to obtain U.S. authorization for its PoNS device. The study's success is crucial for the device's future in the stroke treatment market.
The expansion of the clinical program and the addition of a reputable partner like Brooks Rehabilitation Hospital could be seen as a positive development for Helius Medical. It indicates progress in the clinical validation of the PoNS device, which is essential for regulatory approval and commercial success. If the study yields positive results, it could significantly enhance the company's credibility and market potential, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 70
IMPORTANCE 75
RELEVANCE 80